Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Impact of SARS-Cov-2 Virus Infection on the Endocrine System
Noel Somasundaram, Ishara Ranathunga, Vithiya Ratnasamy, et al.
Journal of the Endocrine Society (2020) Vol. 4, Iss. 8
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study
Daniel Ayoubkhani, Kamlesh Khunti, Vahé Nafilyan, et al.
BMJ (2021), pp. n693-n693
Open Access | Times Cited: 727
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study
Andrea Dennis, Małgorzata Wamil, Johann Alberts, et al.
BMJ Open (2021) Vol. 11, Iss. 3, pp. e048391-e048391
Open Access | Times Cited: 510
Viral infiltration of pancreatic islets in patients with COVID-19
Charlotte Steenblock, Stefanie Richter, Ilona Berger, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 169
COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Mohamd A. Alblihed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 109
A review of cytokine-based pathophysiology of Long COVID symptoms
Russell N. Low, Ryan Low, Athena Akrami
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 103
Multi-organ impairment in low-risk individuals with long COVID
Andrea Dennis, Małgorzata Wamil, Sandeep Kapur, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 125
Insulin resistance in COVID-19 and diabetes
Nalini Govender, Olive P. Khaliq, Jagidesa Moodley, et al.
Primary care diabetes (2021) Vol. 15, Iss. 4, pp. 629-634
Open Access | Times Cited: 103
Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects
Giuseppe Lisco, Anna De Tullio, Emilio Jirillo, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 9, pp. 1801-1814
Open Access | Times Cited: 100
ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors
Zofia Wicik, Ceren Eyileten, Daniel Jakubik, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3743-3743
Open Access | Times Cited: 92
A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome
Doyeon Kim, Sukjun Kim, Joori Park, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 77
The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data
Fares Qeadan, Benjamin Tingey, Jamie Egbert, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266809-e0266809
Open Access | Times Cited: 61
Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study
Daniel Ayoubkhani, Kamlesh Khunti, Vahé Nafilyan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 57
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
Barbara Malinowska, Marta Baranowska‐Kuczko, Aleksandra Kicman, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1986-1986
Open Access | Times Cited: 46
Bromocriptine therapy: Review of mechanism of action, safety and tolerability
Faiza Naz, Abdul Malik, Muhammad Riaz, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 8, pp. 903-922
Closed Access | Times Cited: 29
Assessment of Neuroendocrine Changes and Hypothalamo-Pituitary Autoimmunity in Patients with COVID-19
Mustafa Sait Gönen, Annamaria De Bellis, Emre Durcan, et al.
Hormone and Metabolic Research (2022) Vol. 54, Iss. 03, pp. 153-161
Open Access | Times Cited: 27
Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Sarah Albogami, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1361-1361
Open Access | Times Cited: 25
An overview of COVID‐19 in people with diabetes: Pathophysiology and considerations in the inpatient setting
Nicola Fleming, Lori J. Sacks, Cecilia T. Pham, et al.
Diabetic Medicine (2020) Vol. 38, Iss. 3
Open Access | Times Cited: 39
The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
Mojgan Moshrefi, Saeed Ghasemi‐Esmailabad, Jaffar Ali, et al.
Journal of Assisted Reproduction and Genetics (2021) Vol. 38, Iss. 7, pp. 1691-1708
Open Access | Times Cited: 30
The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect
Yousef Rasmi, Ladan Jalali, Saliha Khalid, et al.
Cytokine (2023) Vol. 169, pp. 156253-156253
Open Access | Times Cited: 13
Severe Acute Respiratory Syndrome–Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research
Philip A. Verhoef, Sujatha Kannan, Jamie Sturgill, et al.
Critical Care Explorations (2021) Vol. 3, Iss. 3, pp. e0374-e0374
Open Access | Times Cited: 25
Does inflammation link stress to poor COVID‐19 outcome?
Steven J. Lamontagne, Diego A. Pizzagalli, Mary C. Olmstead
Stress and Health (2020) Vol. 37, Iss. 3, pp. 401-414
Closed Access | Times Cited: 25
“Post-COVID syndrome”: The focus is on musculoskeletal pain
А. Е. Каратеев, В Н Амирджанова, Е. Л. Насонов, et al.
Rheumatology Science and Practice (2021) Vol. 59, Iss. 3, pp. 255-262
Open Access | Times Cited: 21
Suppression of Pituitary Hormone Genes in Subjects Who Died From COVID-19 Independently of Virus Detection in the Gland
Anello Marcello Poma, Agnese Proietti, Elisabetta Macerola, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 8, pp. 2243-2253
Open Access | Times Cited: 15
Management of Patients With Glucocorticoid-Related Diseases and COVID-19
Irina Chifu, Mario Detomas, Ulrich Dischinger, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 19
Interplay of Vitamin D and <i>CYP3A4</i> Polymorphisms in Endocrine Disorders and Cancer
Siva Swapna Kasarla, Vannuruswamy Garikapati, Yashwant Kumar, et al.
Endocrinology and Metabolism (2022) Vol. 37, Iss. 3, pp. 392-407
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top